A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

NCT01661088 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: FOLFIRINOX
RADIATION: Intensity-modulated radiotherapy (IMRT)
PROCEDURE: Surgical Exploration

Sponsor

University of Michigan Rogel Cancer Center